Moleculin Biotech
| Region | Nordamerika |
| ISIN | US60855D1019 |
| Sektor | Biotechnologie |
| Website | http://www.moleculin.com/ |
Moleculin Biotech is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center, the world’s largest cancer research facility headquartered within the world’s largest medical center.
| Titel | Datum |
|---|---|
| MISC, SHI get BV's nod for 'world's first' ammonia-fueled LR2 tanker powered by PEMFC | vor ungefähr einem Monat |
| MISC, Samsung Heavy Industries get class approval for world's first ammonia-fuelled LR2 tanker design | vor ungefähr einem Monat |
| Stock Today: MISC Dips Amid Mixed Half-Year Results | vor ungefähr 2 Monaten |
| MISC's First Half Earnings Were Within Expectation | vor ungefähr 2 Monaten |
| MISC earnings outlook in 2H weighed by lower shipping rates, LNG supply delays, say analysts | vor ungefähr 2 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Minori Solutions (1 Artikel) | |
| Microsoft (1 Artikel) | |
| Moovly Media (1 Artikel) | |
| MorphoSys (1 Artikel) | |
| Alle anzeigen | |